Vontobel Holding’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.69M | Sell |
13,448
-2,491
| -16% | -$313K | 0.01% | 482 |
|
2025
Q1 | $2.18M | Buy |
15,939
+677
| +4% | +$92.6K | 0.01% | 434 |
|
2024
Q4 | $2.33M | Buy |
15,262
+4,109
| +37% | +$628K | 0.01% | 417 |
|
2024
Q3 | $2.16M | Sell |
11,153
-2,652
| -19% | -$514K | 0.01% | 432 |
|
2024
Q2 | $3.2M | Sell |
13,805
-5,076
| -27% | -$1.18M | 0.01% | 369 |
|
2024
Q1 | $4.07M | Sell |
18,881
-4,049
| -18% | -$873K | 0.03% | 343 |
|
2023
Q4 | $5.93M | Buy |
22,930
+8,499
| +59% | +$2.2M | 0.05% | 285 |
|
2023
Q3 | $3.71M | Sell |
14,431
-1,140
| -7% | -$293K | 0.03% | 330 |
|
2023
Q2 | $4.44M | Buy |
15,571
+4,488
| +40% | +$1.28M | 0.04% | 318 |
|
2023
Q1 | $3.08M | Buy |
11,083
+2,511
| +29% | +$698K | 0.03% | 358 |
|
2022
Q4 | $2.35M | Sell |
8,572
-3,301
| -28% | -$905K | 0.02% | 380 |
|
2022
Q3 | $3.14M | Buy |
11,873
+339
| +3% | +$89.6K | 0.04% | 332 |
|
2022
Q2 | $2.37M | Sell |
11,534
-2,511
| -18% | -$515K | 0.03% | 364 |
|
2022
Q1 | $2.97M | Sell |
14,045
-22,209
| -61% | -$4.69M | 0.03% | 359 |
|
2021
Q4 | $8.7M | Sell |
36,254
-11,370
| -24% | -$2.73M | 0.07% | 204 |
|
2021
Q3 | $13.5M | Buy |
47,624
+4,657
| +11% | +$1.32M | 0.12% | 150 |
|
2021
Q2 | $14.9M | Sell |
42,967
-38,279
| -47% | -$13.2M | 0.13% | 141 |
|
2021
Q1 | $22.7M | Sell |
81,246
-6,810
| -8% | -$1.91M | 0.17% | 93 |
|
2020
Q4 | $23.7M | Buy |
+88,056
| New | +$23.7M | 0.16% | 88 |
|